Healthcare Meeting Sessions

This session provides actuaries with a comprehensive overview of health care cost trends, examining both the retrospective drivers behind recent high trend levels and forward-looking predictions. As the industry faces unprecedented cost increases, understanding the underlying factors is critical for evaluating and implementing effective solutions and strategies. Attendees will gain insights into key cost drivers, emerging trends, and actionable approaches to manage and anticipate future health care expenditures.

A comprehensive discussion on stop loss insurance and captive alternatives. This session covers current stop loss market conditions, captive insurance market conditions, and practical implementation strategies for clients of varying sizes and risk appetites. 

In this session, panelists will discuss current topics in the overall Medicare market.  Potential topics include:  Inflation Reduction Act (IRA) and other recent CMS changes to Medicare Advantage and Part D plans, employer retiree plan topics including creditable coverage determinations, Retiree Drug Subsidy (RDS) calculations, and OPEB valuation, and other current topics impacting the Medicare market overall.

Bias testing and controlling has always been an important part of actuarial practices, but as machine learning and artificial intelligence become more prevalent in our work, the quest has evolved. With technology increasingly functioning as “black boxes,” bias could be harder to detect yet more critical to control. This session brings together perspectives from actuaries, technical experts and independent industry voice, and discusses practical approaches to bias detection, testing, and governance in AI-driven actuarial work.

Going beyond LLMs, AI Agents can automate a complete workflows. This session will present the power of agents and demonstrate some simple agents that can be expanded into extensive workflows.

Executive orders, legislation, regulations, and judicial actions continue to dynamically influence US health policy. This session will provide the latest understanding of these developments, as well as plan sponsor and health plan impacts – and how they are strategizing go-forward responses.

Explore emerging alternatives to traditional healthcare benefits with industry leaders reshaping the marketplace. This session covers innovative funding models including ICHRAs, direct primary care, along with new approaches to quality measurement that prioritize provider performance over facility reputation.

When actuaries are asked to opine on innovative products or solutions, how far are we to stretch beyond our direct experiences? As new healthcare data sources appear at unprecedented rate, are we truly experts or still beginners learning the domain? Join this session for a candid discussion on how to navigate actuarial professionalism in a new era of data, technology, and innovation.